"Millions of Americans are turning to anxiety medications, a trend fueled by increased stressors and greater accessibility, yet a vocal segment of public figures claims these drugs are harmful, sparking debate amidst growing evidence of their efficacy."
The use of anxiety medications has surged across the United States, with a notable increase observed between 2019 and 2024, particularly during the COVID-19 pandemic. This rise, affecting approximately 8 million more individuals and bringing the total to around 38 million adults, is especially pronounced among young adults, college graduates, and the LGBTQ+ community. While psychiatric medications gain broader acceptance and telehealth expands access, this trend has ignited controversy, with some public figures questioning the safety and necessity of widely prescribed antidepressants like SSRIs, contrasting sharply with the views of many clinicians and researchers who advocate for their proven benefits in managing anxiety disorders.
Sadia Zapp, a 40-year-old communications director from New York, exemplifies the growing reliance on these medications. After enduring a grueling year of chemotherapy, surgery, and radiation for breast cancer, she experienced a profound and distracting level of anxiety. "Every little ache, like my knee hurts," she recounted, "made me worry that this is the end of the road for me." This overwhelming anxiety led her to seek professional help, ultimately beginning a regimen of Lexapro, a selective serotonin reuptake inhibitor (SSRI). "I love it. It’s been great," Zapp shared. "It’s really helped me manage." Her experience highlights the personal impact of anxiety and the relief that medication can offer.
The proportion of American adults taking anxiety medications climbed from 11.7% in 2019 to 14.3% in 2024, according to recent survey data from the Centers for Disease Control and Prevention (CDC). This increase, largely concentrated during the COVID-19 pandemic, represents a significant societal shift in mental health treatment. The data reveals sharp upticks among younger demographics, individuals with higher education levels, and those identifying as LGBTQ+, suggesting a confluence of factors contributing to this trend, including increased awareness, reduced stigma, and perhaps heightened societal pressures.
The growing acceptance and accessibility of psychiatric medications, facilitated by the proliferation of telehealth services, have coincided with a public backlash from certain quarters, notably from proponents of the "Make America Healthy Again" movement. These critics argue that SSRIs, a class of antidepressants that includes widely used drugs like Prozac, Zoloft, and Lexapro, are harmful and potentially addictive. However, medical professionals and researchers largely maintain that these medications are front-line treatments for various anxiety disorders, including generalized anxiety disorder and panic disorder, and have demonstrated safety for long-term use, refuting claims of widespread harm and addiction.
Prominent figures have voiced strong reservations about the expanding use of SSRIs. Robert F. Kennedy Jr., Secretary of Health and Human Services, has been a vocal critic. During his confirmation hearing on January 29, he stated his knowledge of individuals, including family members, who found discontinuing SSRIs more challenging than quitting heroin. More recently, he indicated that his agency is investigating a potential link between SSRI use and other psychiatric medications with violent behavior, such as school shootings. Similarly, Food and Drug Administration Commissioner Marty Makary has suggested that SSRI use during pregnancy might be associated with adverse birth outcomes.
These assertions stand in contrast to the medical consensus. While SSRIs can have common side effects such as upset stomach, brain fog, and fatigue, and some may impact libido, many patients find these effects manageable, and the benefits of treating chronic anxiety outweigh the drawbacks. Dr. Patrick Kelly, president of the Southern California Psychiatric Society, characterized the criticisms leveled against SSRIs as lacking evidence. "The statements about SSRIs were just not grounded in any sort of evidence or fact," Kelly commented on Kennedy’s remarks, emphasizing that for many, these medications are a vital tool for managing debilitating anxiety.
Comprehensive research supports the efficacy of SSRIs. A recent study indicated that over half of individuals with generalized anxiety disorder experienced a reduction of at least 50% in their anxiety symptoms while taking an SSRI. Discontinuation due to side effects was reported by approximately 1 in 12 patients. Dr. Emily Wood, a psychiatrist practicing in Los Angeles, underscored the importance of combining medication with appropriate therapy. "When it’s being done right and when you’re also using appropriate therapy techniques, SSRIs can be really, really helpful," she stated, highlighting their role as a cornerstone of treatment when implemented correctly.
The "Make America Healthy Again" (MAHA) movement attributes the rise in anxiety and other mental health issues partly to poor dietary choices and sedentary lifestyles. They advocate for reducing the consumption of ultra-processed foods, which recent studies have linked to depression and anxiety, and promoting exercise over excessive screen time. While psychiatrists often recommend a healthy diet and regular exercise as adjunctive therapies for anxiety and depression, they also acknowledge the crucial role of medication. Dr. Wood also noted that for individuals who can manage their anxiety without medication, talk therapy remains a valuable option, particularly cognitive behavioral therapy, which has shown significant responsiveness for anxiety disorders.
Regarding concerns about SSRIs during pregnancy, research suggests that the risks to both mother and child are low. Dr. Wood expressed concern that recent government statements might inadvertently cause harm by discouraging necessary treatment. "Depression increases your risk for every complication for a mother and a baby," she cautioned, implying that untreated maternal depression can pose greater risks than carefully managed SSRI use.
The issue of addiction to SSRIs is also a point of contention. While benzodiazepines, such as Xanax, which are often used as a second-line treatment for acute anxiety, can be habit-forming and carry risks of dependence, SSRIs are not considered addictive in the same way. Dr. Kelly firmly stated, "The concept of addiction simply does not apply to these chemicals," a sentiment supported by scientific studies. However, discontinuing SSRIs, particularly abruptly, can lead to withdrawal symptoms like nausea and insomnia, a phenomenon known as antidepressant discontinuation syndrome. Benzodiazepines, on the other hand, require careful tapering to avoid dependence and withdrawal. Dr. Wood noted that these medications are effective for short-term, acute anxiety but are not ideal for long-term management due to their habit-forming potential.
Beyond SSRIs and benzodiazepines, an increasing number of individuals are also utilizing beta-blockers, such as propranolol, for anxiety. These medications, often prescribed off-label, are sometimes used to manage the physical symptoms of anxiety, like a racing heart, before high-pressure events such as public speaking. While beta-blockers can cause dizziness and fatigue, they are considered nonaddictive and can be effective in calming the body’s stress response.
The surge in anxiety medication use is likely multifactorial. Leading theories from physicians and researchers point to increased social media engagement, greater social isolation, and heightened economic uncertainty as significant contributors to rising anxiety levels. The COVID-19 pandemic, with its lockdowns and disruptions, exacerbated these stressors, particularly for young adults. Furthermore, the increased accessibility of healthcare, including the convenience of obtaining prescriptions through primary care physicians and telehealth appointments, has made it easier for individuals to seek and receive treatment.
Social media plays a dual role in this landscape. While influencers openly discussing their mental health struggles can help reduce stigma and encourage help-seeking behaviors among young people, it also contributes to a trend of self-diagnosis based on online information. A simple Google search for "buy Xanax online" can yield sponsored results promising rapid treatment, though often with disclaimers about prescription requirements. This highlights a critical distinction between accessing legitimate medical care and the potentially dangerous practice of attempting to procure medication without proper medical oversight.
Young adults, in particular, are driving the increase in anxiety medication use. The proportion of Americans aged 18 to 34 taking anxiety medication rose significantly from 8.8% in 2019 to 14.6% in 2024, according to CDC data. This contrasts with a more stable rate among older adults. The pandemic’s impact on this age group, coupled with broader societal changes, likely contributes to this trend. Data also indicates that women are more likely than men to take anxiety medication, a phenomenon that experts attribute to several factors, including a higher likelihood of needing such medication, a greater propensity to report anxious feelings, and a tendency for healthcare providers to recognize and address anxiety in female patients more readily.
Sociological factors also play a role in the growing prevalence of anxiety. Dr. Jason Schnittker, a sociologist and author, suggests that increasing income inequality, the erosion of traditional social and religious activities, and a general increase in societal suspicion may contribute to heightened stress and unease across generations. His book, "Unnerved: Anxiety, Social Change, and the Transformation of Modern Mental Health," explores these complex societal dynamics.
For Sadia Zapp, the journey to managing her anxiety involved a combination of medication and therapy. After several months on Lexapro, she experienced a significant reduction in the "noise" in her mind, allowing for improved focus. While she initially utilized talk therapy, she has since found that medication alone has stabilized her chronic anxiety. "It definitely helped me get back to my day-to-day in a way that was productive and not just riddled with my anxieties throughout the day," she reflected, underscoring the life-changing impact of effective treatment. Her experience, like that of millions of others, illustrates the profound positive impact that well-managed anxiety medication can have on an individual’s quality of life, even amidst ongoing societal debates about its use.